The insulin-degrading enzyme (IDE) possesses a strong ability to degrade insulin and Aβ42 that has been linked to the neurodegeneration in Alzheimer’s disease (AD). The gene discussed is IDE; the disease is early-onset autosomal dominant Alzheimer disease.